Psychiatr. praxi. 2013;14(4):146-148

Metabolic syndrome in bipolar disorder

MUDr.Jan Hubeňák
Psychiatrická klinika LF UK a FN v Hradci Králové

Bipolar affective disorder is a chronic disease connected with a high occurence of cardiovascular and metabolic morbidity and mortality

as well. Despite these findings, bipolar patients are not obtaining equal standard of medical care for their somatic diseases as general

population. Monitoring of physical health by psychiatrists is therefore necessary.

Keywords: bipolar affective disorder, metabolic syndrome

Published: November 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hubeňák J. Metabolic syndrome in bipolar disorder. Psychiatr. praxi. 2013;14(4):146-148.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Briskman I, Bar G, Boaz M, Shargorodsky M. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital. Int J Psychiatry Med 2012; 43(4): 339-348. Go to original source... Go to PubMed...
    2. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002; 68(2-3): 167-181. Go to original source... Go to PubMed...
    3. Laursen TM, Wahlbeck K, Hällgren J, Westman J, Ösby U, Alinaghizadeh H, Gissler M, Nordentoft M. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. PLoS One 2013; 24; 8(6): e67133. Publikováno online 24. června 2013. Go to original source... Go to PubMed...
    4. Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011; 131(1-3): 101-104. Go to original source... Go to PubMed...
    5. Westman J, Hällgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open 2013 18; 3(4): 1-8. Go to original source... Go to PubMed...
    6. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv. 2009; 60(2): 147-156. Go to original source... Go to PubMed...
    7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595-1607. Go to original source... Go to PubMed...
    8. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366(9491): 1059-1062. Go to original source... Go to PubMed...
    9. Executive summary: The third report of the national cholesterol education program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 2001; 285: 2486-2497. Go to original source... Go to PubMed...
    10. McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HT, Kahn LS, Kucyi A, Soczynska JK, Woldeyohannes HO, Lachowski A, Kim B, Nathanson J, Alsuwaidan M, Taylor VH. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord. 2010; 126(3): 366-387. Go to original source... Go to PubMed...
    11. Maina G, Salvi V, Vitalucci A, D'Ambrosio V, Bogetto F. Prevalence and correlates of overweight in drug-na?ve patients with bipolar disorder. J Affect Disord. 2008; 110(1-2): 149-155. Go to original source... Go to PubMed...
    12. Fagiolini A, Chengappa KN, Soreca I, Chang J. Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs 2008; 22(8): 655-669. Go to original source... Go to PubMed...
    13. Fagiolini A, Kupfer DJ, Rucci P, Scott JA, Novick DM, Frank E. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry 2004; 65(4): 509-514. Go to original source... Go to PubMed...
    14. McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005; 17(2): 83-93. Go to original source... Go to PubMed...
    15. Goldstein BI, Liu SM, Schaffer A, Sala R, Blanco C. Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord. 2013; 15(3): 284-293. Go to original source... Go to PubMed...
    16. Lee NY, Kim SH, Cho B, Lee YJ, Chang JS, Kang UG, Kim YS, Ahn YM. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(7): 1243-1249. Go to original source... Go to PubMed...
    17. Czepielewski L, Filho LD, Brietzke E, Grassi-Oliveira R. Bipolar disorder and metabolic syndrome: a systematic review. Rev Bras Psiquiatr 2012; 35(1): 88-93. Go to original source... Go to PubMed...
    18. Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, McIntyre RS. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromolecular Med. 2011; 13(2): 93-116. Go to original source... Go to PubMed...
    19. Gos T, Schroeter ML, Lessel W, Bernstein HG, Dobrowolny H, Schiltz K, Bogerts B, Steiner J. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem study. J Psychiatr Res. 2013. Publikováno online 26. července 2013. Go to original source...
    20. Schroeter ML, Abdul-Khaliq H, Sacher J, Steiner J, Blasig IE, Mueller K. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol. 2010; 2010: 780645. Go to original source... Go to PubMed...
    21. Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010; 67(4): 360-368. Go to original source... Go to PubMed...
    22. Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gonçalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res. 2010; 44(14): 903-909. Go to original source... Go to PubMed...
    23. Mansur RB, Cha DS, Asevedo E, McIntyre RS, Brietzke E. Selfish brain and neuroprogression in bipolar disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013; 43: 66-71. Go to original source... Go to PubMed...
    24. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004; 28(2): 143-180. Go to original source... Go to PubMed...
    25. Peters A, Kubera B, Hubold C, Langemann D. The corpulent phenotype-how the brain maximizes survival in stressful environments. Front Neurosci. 2013; 7: 47. Go to original source... Go to PubMed...
    26. Printz D, Clark J, Stricks L, Malaspina D. Weight Gain in Bipolar Disorder: Causes and Treatments. Primary Psychiatry 2003; 10(11): 29-36.
    27. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15(1): 1-44. Go to original source... Go to PubMed...
    28. Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV 3rd, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013; 368(17): 1594-1602. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.